This Article Full Text Full Text (PDF) All Versions of this Article: 1055-9965.EPI-07-2656v1 17/6/1374    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Grunau, C. Articles by De Sario, A. Search for Related Content PubMed PubMed Citation Articles by Grunau, C. Articles by De Sario, A. Related Collections Oncogenesis: Biomarkers Early Detection Early Detection: Biomarkers: Discovery, Methodology, Validation

BAGE Hypomethylation, A New Epigenetic Biomarker for Colon Cancer Detection

¹ Institut de Génétique Humaine, Centre National de la Recherche Scientifique UPR 1142, Montpellier, France; ² Ecole Supérieure de Physique et de Chimie Industrielles, Paris, France; ³ CHU Purpan, Toulouse, France; and ⁴ Institute for Pathology, Friedrich-Schiller University, Jena, Germany

Requests for reprints: Albertina De Sario, Centre National de la Recherche Scientifique UPR 1142, 141 rue de la Cardonille, 34396 Montpellier, France. Phone: 33-4996-19977; Fax: 33-4996-19901. E-mail: Albertina.de-Sario{at}igh.cnrs.fr

Early detection of colorectal cancer is a decisive step in the successful and complete cure of the disease. Epigenetic markers, in particular, those based on aberrant DNA methylation, can be used to diagnose cancer. B melanoma antigens (BAGE) are a family of genes and truncated genes located in the heterochromatic regions of several human chromosomes. Our previous work showed that BAGE loci (i.e., genes and truncated genes) were hypermethylated in normal tissues and hypomethylated in 98% of human cancers. In the present study, we analyzed DNA methylation of the BAGE loci in 54 colon cancers and in neighboring histopathologic normal tissue samples. Using a combined bisulfite restriction assay, we showed that BAGE loci were hypomethylated in 81% of carcinoma samples. Colon cancer could be diagnosed with 94% specificity, 83% sensitivity, and 89% accuracy. No correlation was found between DNA methylation of BAGE loci and age, gender of patients, nor with the tumor stage or site. Based on the hypothesis that during neoplastic transformation, hypomethylation occurs in juxtacentromeric CpG islands, we suggest that other genes located in the heterochromatic compartment should be tested. These new markers enrich the list of currently studied epigenetic alterations in colon cancer and could be associated with hypermethylation markers to develop reliable diagnostic tests. (Cancer Epidemiol Biomarkers Prev 2008;17(6):1374–9)

This article has been cited by other articles:

				S. Ogino, K. Shima, K. Nosho, N. Irahara, Y. Baba, B. M. Wolpin, E. L. Giovannucci, J. A. Meyerhardt, and C. S. Fuchs A Cohort Study of p27 Localization in Colon Cancer, Body Mass Index, and Patient Survival Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1849 - 1858. [Abstract] [Full Text] [PDF]